The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
From Its 2026 Market Size, What Value Is The Intermittent Claudication Market Projected To Reach By 2030?
The intermittent claudication market size has seen significant growth in recent years. It is anticipated to increase from $13.51 billion in 2025 to $14.31 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.9%. This past growth can be attributed to factors such as the rising prevalence of peripheral artery disease, an expanding aging population, a high incidence of smoking-related vascular disorders, an increase in the burden of cardiovascular diseases, and the wider availability of vascular intervention procedures.
The intermittent claudication market is projected to experience substantial expansion over the next few years. It is expected to reach a value of $17.98 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.9%. This anticipated growth during the forecast period is primarily due to increasing awareness of peripheral artery disease symptoms, the rising demand for minimally invasive vascular treatments, advancements in pharmacological therapies, the growing adoption of home-based disease management, and improved screening and diagnostic programs. Prominent trends for the forecast period include a heightened focus on early diagnosis of peripheral artery disease, an increase in the adoption of combination drug therapies, a growing preference for minimally invasive revascularization procedures, the expansion of supervised exercise therapy programs, and enhanced patient awareness and disease management.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/report/intermittent-claudication-global-market-report
What Factors Are Contributing To The Growth Of The Intermittent Claudication Market?
The intermittent claudication market is anticipated to grow as a result of the rising number of peripheral artery disease (PAD) cases. Peripheral artery disease is a circulatory condition where narrowed arteries restrict blood flow to the limbs, causing pain, numbness, and other complications. The increase in peripheral artery disease cases is attributed to factors such as an aging population, diabetes, smoking, hypertension, obesity, and inactive lifestyles. Peripheral artery disease (PAD) leads to intermittent claudication by reducing blood flow to leg muscles during exercise, causing pain and cramping due to a lack of oxygen. For instance, in June 2023, according to the American Heart Association Journals, a US-based peer-reviewed open-access scientific journal, peripheral artery disease (PAD) affects 7-12 million in the U.S. and 200 million globally. Therefore, the growing incidence of peripheral artery disease (PAD) is fueling the expansion of the intermittent claudication market.
Which Segment Categories Are Included In The Intermittent Claudication Market Segment Analysis?
The intermittent claudication market covered in this report is segmented –
1) By Type: Medication Therapies, Revascularization
2) By Route Of Administration: Parenteral Route, Oral Route, Other Routes Of Administration
3) By Application: Hospitals, Clinics, Home Healthcare, Other Applications
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Medication Therapies: Antiplatelet Agents, Vasodilators, Phosphodiesterase Inhibitors, Cilostazol, Pentoxifylline
2) By Revascularization: Angioplasty, Stenting, Bypass Surgery, Endarterectomy
What Trends Are Shaping The Future Of The Intermittent Claudication Market?
Leading companies in the Intermittent Claudication market are increasingly focusing on integrating minimally invasive endovascular innovations, such as percutaneous bypass systems, to improve treatment effectiveness, procedural success, and patient outcomes. Percutaneous bypass systems are advanced vascular technologies that create an endovascular bypass pathway utilizing specialized stent grafts and catheters, thereby enabling functions like restoring blood flow across extensive arterial blockages, decreasing reliance on open surgical bypass, and supporting faster patient recovery. As an illustration, in June 2023, Endologix LLC, a US-based medical device firm specializing in vascular disease therapies, gained FDA approval for its DETOUR System. This system is a minimally invasive percutaneous bypass solution specifically designed to address long, complex superficial femoropopliteal lesions in individuals with peripheral artery disease (PAD). The DETOUR System incorporates the TORUS stent graft platform, a new endovascular bypass technique, and offers the ability to treat long-segment occlusions, thus facilitating the effective management of challenging femoropopliteal blockages. This system enhances the restoration of blood flow, minimizes procedural complications, and expands the available treatment choices for patients with symptomatic PAD and Intermittent Claudication.
Who Are The Active Companies Shaping The Intermittent Claudication Market?
Major companies operating in the intermittent claudication market are Pfizer Inc., Bristol Myers Squibb Company, AstraZeneca PLC, Novartis AG, Teva Pharmaceutical, Otsuka Pharmaceutical Co. Ltd., Sanofi S.A., Bayer AG, Hikma Pharmaceuticals PLC, Dr. Reddy’s Laboratories, Alkem Laboratories, Aastrid Life Sciences Pvt. Ltd., Manus Aktteva Biopharma LLP, Enomark Pharma.
Get The Full Intermittent Claudication Market Report:
https://www.thebusinessresearchcompany.com/report/intermittent-claudication-global-market-report
Which Geographic Region Dominates The Intermittent Claudication Market?
North America was the largest region in the intermittent claudication market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intermittent claudication market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Intermittent Claudication Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/intermittent-claudication-global-market-report
Browse Through More Reports Similar to the Global Intermittent Claudication Market 2026, By The Business Research Company
Hearing Loop Market Report 2026
https://www.thebusinessresearchcompany.com/report/hearing-loop-global-market-report
Peripheral Arterial Disease Market Report 2026
https://www.thebusinessresearchcompany.com/report/peripheral-arterial-disease-global-market-report
Muscle Spasticity Market Report 2026
https://www.thebusinessresearchcompany.com/report/muscle-spasticity-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model